Endoscopic Band Ligation (EBL) Versus Endoscopic Band Ligation and Propranolol for the Prevention of Variceal Rebleeding
- Conditions
- CirrhosisVariceal Bleeding
- Interventions
- Procedure: EBL+PropranololProcedure: endoscopic band ligation
- Registration Number
- NCT00966121
- Lead Sponsor
- Korea University
- Brief Summary
Both propranolol and endoscopic band ligation (EBL) are effective for prevention of variceal rebleeding. Recently several studies compared the efficacy of EBL alone and with a combination of propranolol and EBL. However, the results of recent studies showed discrepancy. This study is performed to compare the efficacy and safety of EBL alone and EBL combined with propranolol in patients without previous history of endoscopic variceal treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 180
- liver cirrhosis
- age between 18 and 70 years
- Successful control of esophageal variceal bleeding within 6 weeks before enrollment
- Gastric variceal bleeding
- Patients with systolic blood pressure <100 mmHg or basal heart rate <60/min
- Portal vein thrombosis
- Prominent hepatic encephalopathy
- Coexisting untreated malignancy
- Severe cerebrovascular or cardiovascular disease, renal failure
- Previous history of endoscopic, radiologic, or surgical treatment for varices or ascites
- Contraindication to beta-blocker
- Pregnancy
- Refusal to give consent to participate in the trial
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description EBL+Propranolol EBL+Propranolol Perform EBL same as EBL group. In addition, take propranolol to reduce 25% in HR or HR ≤55/min Endoscopic band ligation endoscopic band ligation Perform endoscopic band ligation (EBL) until esophageal varices are eradicated, and then follow-up endoscopy with 3-6 months interval
- Primary Outcome Measures
Name Time Method Rebleeding from esophageal varices 2 years Rebleeding from esophageal varices
- Secondary Outcome Measures
Name Time Method Upper gastrointestinal bleeding; significant esophageal variceal bleeding; mortality;adverse events 2 years Upper gastrointestinal bleeding; significant esophageal variceal bleeding; mortality;adverse events
Trial Locations
- Locations (1)
Korea University Anam Hospital
🇰🇷Seoul, Korea, Republic of